A subscription to JoVE is required to view this content. Sign in or start your free trial.
Typical microtubule inhibitors, used widely in basic and applied research, have far-reaching effects on cells. Recently, photostatins emerged as a class of photoswitchable microtubule inhibitors, capable of instantaneous, reversible, spatiotemporally precise manipulation of microtubules. This step-by-step protocol details the application of photostatins in a 3D live preimplantation mouse embryo.
The microtubule cytoskeleton forms the framework of a cell and is fundamental for intracellular transport, cell division, and signal transduction. Traditional pharmacological disruption of the ubiquitous microtubule network using, for instance, nocodazole can have devastating consequences for any cell. Reversibly photoswitchable microtubule inhibitors have the potential to overcome the limitations by enabling drug effects to be implemented in a spatiotemporally-controlled manner. One such family of drugs is the azobenzene-based photostatins (PSTs). These compounds are inactive in dark conditions, and upon illumination with UV light, they bind to the colchicine-binding site of β-tubulin and block microtubule polymerization and dynamic turnover. Here, the application of PSTs in the 3-dimensional (3D) live preimplantation mouse embryo is set out to disrupt the microtubule network on a subcellular level. This protocol provides instructions for the experimental setup, as well as light activation and deactivation parameters for PSTs using live-cell confocal microscopy. This ensures reproducibility and enables others to apply this procedure to their research questions. Innovative photoswitches like PSTs may evolve as powerful tools to advance the understanding of the dynamic intracellular microtubule network and to non-invasively manipulate the cytoskeleton in real-time. Furthermore, PSTs may prove useful in other 3D structures such as organoids, blastoids, or embryos of other species.
The microtubule architecture varies widely across different cell types to support diverse functions1,2. Its dynamic nature of growth and shrinkage allows rapid adaptation to extra- and intracellular cues and to respond to the ever-changing needs of a cell. Hence, it can be considered as the "morphological fingerprint" playing a key role in cellular identity.
Pharmacological targeting of the microtubule cytoskeleton using small molecule inhibitors has led to a plethora of fundamental discoveries in developmental biology, stem cell biology, cancer biology, and neurobiology
Experiments were approved by the Monash Animal Ethics Committee under animal ethics number 19143. Animals were housed in specific pathogen-free animal house conditions at the animal facility (Monash Animal Research Platform) in strict accordance with ethical guidelines.
1. Preimplantation mouse embryo collection
In line with the protocol, preimplantation mouse embryos were microinjected with cRNA for EB3, tagged with red fluorescent dTomato (EB3-dTomato). This enables the visualization of growing microtubules as EB3 binds to polymerizing microtubule plus ends24.
The experiments were performed 3 days post-fertilisation (E3) when the mouse embryo is comprised of 16 cells. Any other preimplantation developmental stage can be used, depending on the scientific question to be investi.......
The microtubule network is integral to the fundamental inner workings of a cell. Consequently, this presents challenges in manipulating microtubule dynamics in living organisms, as any perturbation to the network tends to have widespread consequences for all aspects of cellular function. The emergence of photoswitchable microtubule-targeting compounds presents a way to precisely manipulate the cytoskeleton at a subcellular level, with superior control for the induction and reversal of microtubule growth inhibition
The authors would like to thank Dr. Oliver Thorn-Seshold and Li Gao for providing us with photostatins and advice on manuscript preparation, Monash Production for filming support, and Monash Micro Imaging for microscopy support.
This work was supported by the National Health and Medical Research Council (NHMRC) project grant APP2002507 to J.Z. and the Canadian Institute for Advanced Research (CIFAR) Azrieli Scholarship to J.Z. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government.
....Name | Company | Catalog Number | Comments |
Aspirator tube | Sigma-Aldrich | A5177 | For mouth aspiration apparatus |
Chamber slides - LabTek | Thermo Fisher Scientific | NUN155411 | |
cRNA encoding for EB3-dTomato | N/A | N/A | Prepared according to manufacturers instructions using mMessage in vitro Transcription kit |
Culture dishes - 35mm | Thermo Fisher Scientific | 150560 | |
Human chorionic growth hormone | Sigma-Aldrich | C8554 | |
Human Tubal Fluid (HTF) medium | Cosmo-Bio | CSR-R-B071 | |
Imaris Image Analysis Software | Bitplane | ||
Immersion Oil W 2010 | Carl Zeiss | 444969-0000-000 | For use with microscope immersion objective |
LED torch - Red light | Celestron | 93588 | |
M2 medium | Sigma-Aldrich | M7167 | |
Mice - wild-type FVB/N, males and females | N/A | N/A | Females 8-9 weeks old. Males 2-6 months old. |
Microcapillary Pipettes - Kimble | Sigma-Aldrich | Z543306 | For mouth aspiration apparatus |
Microinjection buffer | N/A | N/A | 5 mM Tris, 5 mM NaCl, 0.1 mM EDTA, pH 7.4 |
Mineral oil | Origio | ART-4008-5P | |
mMessage In vitro Transcription kit | Thermo Fisher Scientific | AM1340 | |
NanoDrop Spectrophotometer | Thermo Fisher Scientific | ||
Potassium Simplex Optimised Medium (KSOM) medium | Cosmo-Bio | CSR-R-B074 | |
Pregnant mare serum gonadotrophin | Prospec Bio | HOR-272 | |
PST-1P | N/A | N/A | Borowiak, M. et al., Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death. Cell. 162 (2), 403-411, doi:10.1016/j.cell.2015.06.049, (2015). |
RNA purification kit | Sangon | B511361-0100 | |
Ultrapure water | Sigma-Aldrich | W1503 | |
ZEN Black Software | Carl Zeiss |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved